Toxic epidermal necrolysis data from the CELESTE multinational registry. Part II: Specific systemic and local risk factors for the development of infectious complications-Reference-Cited by-同舟云学术

Toxic epidermal necrolysis data from the CELESTE multinational registry. Part II: Specific systemic and local risk factors for the development of infectious complications

Published:2018-09 Issue:6 Volume:44 Page:1561-1572
ISSN:0305-4179
Container-title:Burns
language:en
Short-container-title:Burns

Author:

Lipový B.,Holoubek J.,Hanslianová M.,Cvanová M.,Klein L.,Grossová I.,Zajíček R.,Bukovčan P.,Koller J.,Baran M.,Lengyel P.,Eimer L.,Jandová M.,Košťál M.,Brychta P.

Publisher

Elsevier BV

Subject

Critical Care and Intensive Care Medicine,Emergency Medicine,General Medicine,Surgery

Reference34 articles.

1. Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification;Wolf;Clin Dermatol,2005

2. Pathogenesis and recent therapeutic trends in Stevens–Johnson syndrome and toxic epidermal necrolysis;Khalili;Ann Allergy Asthma Immunol,2006

3. Toxic epidermal necrolysis: review of pathogenesis and management;Downey;J Am Acad Dermatol,2012

4. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis;Paul;Br J Dermatol,1996

5. Acute skin failure: concept, causes, consequences and care;Inamadar;Indian J Dermatol Venereol Leprol,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cohort study of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis in China: evaluation of risk models and new predictor of pulmonary consolidation on computed tomography;Frontiers of Medicine;2021-03-01

2. Impact of Antibiotics Associated with the Development of Toxic Epidermal Necrolysis on Early and Late-Onset Infectious Complications;Microorganisms;2021-01-19

3. The present perspective on the administration of intravenous immunoglobulins in patients with toxic epidermal necrolysis;Klinická farmakologie a farmacie;2020-11-06

4. Responsiveness to i.v. immunoglobulin therapy in patients with toxic epidermal necrolysis: A novel pharmaco‐immunogenetic concept;The Journal of Dermatology;2020-09-15

5. Systemic therapies for Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: a SCORTEN‐based systematic review and meta‐analysis;Journal of the European Academy of Dermatology and Venereology;2020-07-23